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Background: Morus alba has long been used in traditional Chinese medicine to treat inflammatory diseases;
however, the scientific basis for such usage and the mechanism of action are not well understood. This study
investigated the action of M. alba on leukocyte migration, one key step in inflammation.
Methods: Gas chromatography-mass spectrometry (GC-MS) and cluster analyses of supercritical CO2 extracts
of three Morus species were performed for chemotaxonomy-aided plant authentication. Phytochemistry and
CXCR4-mediated chemotaxis assays were used to characterize the chemical and biological properties of M. alba
and its active compound, oxyresveratrol. fluorescence-activated cell sorting (FACS) and Western blot analyses were
conducted to determine the mode of action of oxyresveratrol.
Results: Chemotaxonomy was used to help authenticate M. alba. Chemotaxis-based isolation identified
oxyresveratrol as an active component in M. alba. Phytochemical and chemotaxis assays showed that the crude
extract, ethyl acetate fraction and oxyresveratrol from M. alba suppressed cell migration of Jurkat T cells in response
to SDF-1. Mechanistic study indicated that oxyresveratrol diminished CXCR4-mediated T-cell migration via inhibition
of the MEK/ERK signaling cascade.
Conclusions: A combination of GC-MS and cluster analysis techniques are applicable for authentication of the
Morus species. Anti-inflammatory benefits of M. alba and its active compound, oxyresveratrol, may involve the
inhibition of CXCR-4-mediated chemotaxis and MEK/ERK pathway in T and other immune cells.
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The genus Morus from the Moraceae family consists of
10–16 species of deciduous trees that are distributed
worldwide [1]. Different parts of the Morus plants such
as leaves, fruit, branches, bark, root, and shoot have
been used as food and herbal medicine in China for
over 1900 years [2]. In Taiwan, M. alba, commonly
known as white mulberry, is possibly the Morus species
most frequently used in traditional Chinese medicine* Correspondence: wcyang@gate.sinica.edu.tw
†Equal contributors
1Agricultural Biotechnology Research Center, Academia Sinica, 128, Sec. 2,
Academia Road, Nankang, Taipei 11501, Taiwan
6Department of Life Sciences, National Chung Hsing University, Taichung
402, Taiwan
Full list of author information is available at the end of the article
© 2013 Chen et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the oralthough it is sometimes used interchangeably with
M. atropurpurea and M. bombycis. As all three species
have similar morphological characteristics and habitat
preferences they are frequently misidentified. M. alba,
the most extensively studied species, has been reported
to have anti-hyperlipidemic [3], anti-hypertensive [4,5],
anti-hyperglycemic [2,6]; Hansawasdi, 2006; [7], anti-
microbial [8-12], anti-allergic [13], anti-inflammatory
[14,15], hepatoprotective [16,17], neuroprotective [18],
immuno-modulatory [19], and anti-venom activities
[20].
Photochemical studies have identified alkaloids, flavonoids,
flavones, flavanones, stilbenes, benzophenones, coumarin
derivatives and terpenoids in Morus species [5,21-37]. These
compounds are likely responsible for the bioactivities of thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and resveratrol, were reported present in the Morus plants
and demonstrated antioxidant activity [38]. Oxyresveratrol
inhibited nitrogen oxide (NO) production, inducible NO
synthase (iNOS) expression, prostaglandin E2 (PGE2) pro-
duction, and activation of nuclear factor kappa-light-chain
enhancer of activated B cells (NFκB) in macrophages [39];
and consistently reduced edema induced by carrageenan in
a mouse model [39]. The above data suggest the involve-
ment of oyxresveratrol in suppression of the inflammatory
process. Nevertheless, the role of oxyresveratrol in the regu-
lation of leukocyte migration has not been studied.
Migration of leucocytes from blood vessels to the
flamed sites is a fundamental feature of inflammation.
Chemokines and chemokine receptors can orchestrate
leukocyte migration, also termed chemotaxis [40]. In
addition to its physiological functions, chemotaxis is
implicated in inflammation and disease pathogenesis
[41]. Therefore, chemotaxis has been proposed as a
key target of anti-inflammatory drugs [42]. CXCR4, a
G-protein-linked transmembrane receptor, is expressed
in all leukocytes, blastocysts and a variety of cancer
cells [43]. SDF-1 (CXCL12) is a natural ligand of
CXCR4. After binding to SDF-1, CXCR4 triggers a sig-
naling cascade which includes the activation of kinases
(FAK, PI3K, ERK, JAK, and TYK) and downstream
molecules (NFκB and STAT) and, eventually regulates
chemotaxis, locomotion, and adhesion [43].
Plants provide an extraordinary source of lead com-
pounds for a myriad of disorders including inflamma-
tion. In this study, we investigated the role of M. alba
in leukocyte migration, a key step in inflammation. As
M. alba is easily misidentified due to its close resem-
blance to other Morus plants, we first devised a che-
motaxonomic strategy involving GC-MS analysis and
cluster analysis of the chemical profiles to differentiate
between the Morus species. Next, the anti-chemotactic
activities of M. alba and its active compound, oxy-
resveratrol, were examined in Jurkat T cells. Finally, the
mode of action of M. alba and its active compound,
oxyresveratrol, was investigated.
Methods
Reagents
High performance liquid chromatography (HPLC) grade
solvents, acetonitrile (ACN), dichloromethane, butanol,
methanol and ethyl acetate were purchased from Avantor
Performance Materials (NJ, USA). Trifluoroacetic acid
(TFA), methanol, dimethyl sulfoxide (DMSO), resveratrol
and oxyresveratrol were purchased from Sigmal (MO,
USA). RPMI 1640 medium, PSQ solution (penicillin,
streptomycin and glutamine), sodium pyruvate, non-
essential amino acids and HEPES were purchased from
Gibco (CA, USA). αCXCR4, FITC-conjugated secondaryantibody (Life Technologies, NY, USA) and SDF-1 (R&D
systems, MN, USA) were purchased. WST-1 reagent was
purchased from Roche (Mannheim, Germany). Antibodies
against mitogen-activated protein kinases (MAPKs) and
their phosphorylated proteins were purchased from Cell
Signaling Technology (MA, USA).
Supercritical liquid extraction and GC-MS analysis of plants
M. alba, M. atropurpurea and M. bombycis were
collected and authenticated by Dr Ran-Juh Wang from
the Miaoli District Agricultural Research and Extension
Station (MDARES), Miaoli County, Taiwan, in 2010. Their
voucher specimens were deposited as No. 00083241,
No. 00082146, and No. 00083303, respectively, at the
MDARES herbarium. Branches of the plants were air
dried and pulverized. Five grams of plant samples were
extracted with carbon dioxide using the supercritical fluid
extractor SFX System 1220R (ISCO, NE, USA), followed
by GC-MS analysis using a Trace gas chromatograph
interfaced to a Polaris Q mass spectrometer (Thermo
Finnigan, Hertfordshire, UK) in EI mode (70 eV) as previ-
ously described [44].
Extract preparation, HPLC and compound identification
Branches of Morus plants were pulverized and extracted
with methanol (2 × 3 L). The methanol extracts were
evaporated by rotary evaporator, yielding 1 g of crude
extracts. The M. alba crude extract was re-suspended
with water (150 mL), followed by sequential extraction
with ethyl acetate (9 × 150 mL) and butanol (6 ×150 mL).
Crude extracts, fractions, and oxyresveratrol were ana-
lyzed using an Agilent 1100 Series HPLC system. HPLC
was performed on a Luna C18 column (Phenomenex, CA,
USA) at a flow rate of 0.5 ml/min and 25°C with a photo-
diode detector at 254 nm. The solvent gradient for HPLC
was set in the following sequence, 10% to 50% of B for
0–50 min, 50% of B for 50–65 min, 50 to 100% of B for
65–70 min, and 100% of B for 70 to 95 min. Solvents
A and B were 0.05% TFA/H2O and 0.05% TFA/CAN,
respectively. The identity of oxyresveratrol with a purity
of 97% from M. alba was confirmed by comparing its
spectroscopic data with previously published data [45,46].
Chemotaxis assay and WST-1 assay
Jurkat cells E6.1 (ATCC No. TIB-152), a leukemic T cell
line, were cultured in complete medium as described
[47]. The cells (1 × 106/mL) were pre-treated with crude
extract, fractions, or compounds of M. alba for 24 h in
1% FBS medium. The cells were transferred into a
transwell insert (Millipore, USA) and put into a 24-well
plate where SDF-1 or vehicle (PBS) was added to the 1%
FBS medium. After 4 h, the cells that migrated to the
bottom of the 24-well plate were counted and
photographed. The migration index (MI) was defined
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Figure 1 (See legend on next page.)
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Figure 1 GC-MS profiles and cluster analysis of the three Morus species. (A) Branches of M. alba (MAL), M. atropurpurea (MAT), and
M. bombycis (MBO) underwent supercritical CO2 extraction and GC-MS analysis at a dose of 10 mg/ml. One representative GC-MS chromatogram
from 3 batches of each plant extract is shown. The sizes of the various GC-MS peaks are measured as percent relative area (RA (%)) of the largest
GC-MS peak in the chromatogram. (B) Matrix visualization with hierarchical cluster trees (HCT) for GC-MS profiles of the Morus species.
A representative GC-MS profile of the 3 Morus species from Figure 1 is displayed as a matrix map with 9 rows, each representing one sample, and
70 columns, each representing one retention time. A rainbow spectrum was used to color code the size of the chromatographic peaks
(expressed in percent relative area, RA (%)) in the whole matrix. Red denotes the largest peak (maximum RA (%)) and blue denotes the smallest
peak (minimum RA (%)). (C) Two-way permuted data matrix of (B). The tree structure above the data matrix represents average linkage
hierarchical cluster tree (HCT) for 70 different retention times. (D) Map of correlation matrix for the 9 samples (three samples per species).
A bi-directional blue–white–red spectrum is used to denote negative-to-positive correlation. The tree structure besides the correlation matrix
represents average linkage HCT for 9 samples. (E) Identical data matrix map as in (B) except each column is colored using a rainbow color
spectrum scaled individually for that particular column instead of a rainbow color spectrum scaled for all columns in the matrix.
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grating toward SDF-1 minus number of drug-treated
cells migrating toward PBS)/(number of vehicle-treated
cells migrating toward SDF-1 minus number of vehicle-
treated cells migrating toward PBS) [47]. For WST-1
assay, Jurkat cells (1 × 106/mL) were incubated with the
crude extract, fractions and compound for 24 h. After
PBS washing, the cells were incubated with WST-1 for
1 h and measured at 440 nm using the BioTek ELISA
reader (VT, USA).
Western blot and FACS analysis
Jurkat cells were pre-treated with vehicle and compounds
at the indicated concentrations for 1 h. For Western blot,
the cells were stimulated with SDF-1 for the indicated
time. Total lysates underwent sodium dodecyl sulfate
polyacrylamide gel electrophoresis and blotting with the
indicated antibodies, followed by ECL visualization. To de-
termine the CXCR4 expression level, the cells were
stained with αCXCR4 and secondary antibody and under-
went FACS analysis using FlowJo software.
Statistical analysis
Data from three experiments or more are presented as
mean ± standard deviation. Comparisons between experi-
mental groups and control were made using ANOVA.
P values (*) less than 0.05 were considered statistically
significant.
Results
GC-MS chromatograms and cluster analysis of the
chemical profiles of Morus species
Correct authentication of medicinal plants is an essential
prerequisite to ensure reproducible quality and efficacy
of herbal medicine. M. alba, M. atropurpurea and
M. bombycis are all common in Taiwan. However, their
dried samples and products are frequently indistinguish-
able. For this purpose, a combination of GC-MS and
cluster analysis tools were used to rapidly distinguish the
three Morus species. First, GC-MS analysis of the super-
critical CO2 extracts was used to profile the chemicalcompositions of the three species (Figure 1A). Peaks A
to J are shown in Figure 1. As previously described
[48,49], cluster analysis tools, such as hierarchical cluster
trees (HCT), principal component analysis (PCA) and
multidimensional scaling (MDS), were next used to
analyze the inter- and intra-species chemical variations.
In this work, we adopted HCT with matrix visualization
(MV) in generalized association plots (GAP) [50,51] to
compare the similarities and differences in the chemical
profiles of the Morus extracts (Figure 1A). Figure 1B
shows the matrix visualization of the sizes of the GC-
MS peaks in percent relative areas [RA (%); area of a
GC-MS peak normalized against the area of the largest
peak in the chromatogram, presented as a percentage] of
9 samples (3 samples of each species) with 70 retention
times between 26.22 min and 49.86 min. A rainbow
spectrum was used to color code the sizes of the chro-
matographic peaks with red denoting the largest peak
[maximum RA(%)] and blue denoting the smallest peak
[minimum RA(%)]. Each row in Figure 1B represents
one sample while each column represents one particular
retention time. Average linkage hierarchical cluster trees
(HTCs) for retention time and for samples were then
built on corresponding correlation matrices for retention
time and samples, respectively. Figure 1C is obtained
from the two-way permutation according to the orders
of terminal nodes in HCTs for retention time and
samples in order to obtain sample cluster structure
and retention time grouping pattern [51]. In Figure 1D,
a bi-directional blue-white-red spectrum is used to de-
note negative-to-positive correlation. The most profound
observation to be noted in Figure 1D was that
M. atropurpurea and M. bombycis samples form a larger
group with high positive within-group correlation (in
dark red) while M. alba samples form a separate cluster.
By converting Figure 1C to Figure 1E using individu-
ally ranged color spectra for each retention time so that
between-variant structure within each retention time
(column) can be clearly depicted, we found that the
combination of matrix visualization for GC-MS chemical
profiles with hierarchical cluster trees using GAP was a
Chen et al. BMC Complementary and Alternative Medicine 2013, 13:45 Page 5 of 10
http://www.biomedcentral.com/1472-6882/13/45fast and reliable chemotaxonomical method to assist in
the identification of the three Morus species. In Figure 1E,
the GC-MS peaks of M. alba (MAL), M. atropurpurea
(MAT) and M. bombycis (MBO) are relatively larger than
others with retention time in groups a, b and c, respec-
tively. By selecting the components of groups a, b, and c in
Figure 1E and significant relative peak areas in Figure 1C,
we identified peaks J, G, I, and E (Figure 1C) as useful
parameters to distinguish between the three species.
Overall, the combination of GC-MS and cluster tools
is feasible and suitable for determining the taxonomy of
the Morus species.
HPLC profiles of the three Morus plant extracts
Having authenticated the M. alba, M. atropurpurea, and
M. bombycis branches, we next sought to characterize
their chemical properties. HPLC is a useful method for
analysis and comparison of chemical fingerprints of plant
extracts. HPLC analysis showed similar and distinct peaks
among the 3 Morus species (Figure 2). The peaks at
the retention times, 14.0, 31.3, 64.7, 74.0 and 77.6 min,
appeared in all three species despite the difference in the
relative amount of the peaks. Of note, peak 1 at the reten-
tion time of 31.3 min was present in the crude extracts of
the three Morus species. In contrast, M. alba had a more
abundant peak 1 than M. atropurpurea and M. bombycis.
Peak 1 was isolated from the M. alba extract and identi-
fied as oxyresveratrol as shown in Figure 3. The NMR
data (Additional file 1: Table S1), UV spectra dataFigure 2 HPLC profiles of the crude extracts of the three Morus speci
were analyzed using an RP-18 HPLC column and detected with a UV detec(Additional file 1: Figure S1A) and MS data (Additional
file 1: Figure S1B) of oxyresveratrol in the study were analyzed
and confirmed with those described elsewhere [45,46].
Characterization of M. alba extract using a combination
of phytochemical and chemotaxis assays
M. alba has long been used as anti-inflammatory medi-
cine. To further understand the anti-inflammtory activity
of M. alba, a chemotaxis-guided fractionation and isola-
tion strategy was adopted (Figure 3A). HPLC analysis of
the crude extract, fractions and oxyresveratrol, an active
compound, of M. alba showed that oxyresveratrol (peak 1)
was present in the crude extract (CE, Figure 3B) and ethyl
acetate fraction (EA, Figure 3B) of M. alba; however,
oxyresveratrol was not detectable in the butanol (BuOH,
Figure 3B) and water (H2O, Figure 3B) fractions ofM. alba.
Examination of the effect of the crude extract,
fractions and oxyresveratrol of M. alba on CXCR4-
mediated chemotaxis further showed that the M. alba
crude extract and the ethyl acetate fraction inhibited
chemotaxis in Jurkat T cells, key players in immune re-
sponse (Figure 4A). In contrast, the butanol and water
fractions of M. alba did not inhibit CXCR4-mediated
chemotaxis (Figure 4A). Consistently, oxyresveratrol
dose-dependently inhibited CXCR4-mediated chemo-
taxis in T cells (Figure 4B). This inhibition by the crude
extract, fractions and oxyresveratrol of M. alba was not
due to cytotoxicity because treated cells showed high
viability (Figure 4C). Overall, the data suggest thates. Methanol crude extracts of each species at a dose of 25 mg/ml
tor at 254 nm. Peak 1 (oxyresveratrol) is indicated.
Figure 3 Chemotaxis-based chemical analysis of M. alba. (A) Flow chart of the bioactivity-directed fractionation and isolation (BDFI) analysis.
A M. alba branch was ground and extracted with methanol (MeOH). The crude extract (CE) was tested for bioactivity using chemotaxis assay. The
same crude extract was sequentially partitioned with ethyl acetate (EA), butanol (BuOH and water (H2O). The bioactivity of the 3 fractions was
further tested. Finally, active compound, oxyresveratrol, was purified from the active EA fraction. The dry weights of the crude extract, fractions
and compound of M. alba are indicated as percentages of the dry weight of the raw plant material. (B) HPLC profiles of methanol crude extract
(CE), ethyl acetate fraction (EA), butanol fraction (BuOH), water fraction (H2O) and oxyresveratrol with UV detection at 254 nm. Peak 1 is identified
as oxyresveratrol.
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inhibition of leukocyte migration.Mechanistic study of oxyresveratrol in CXCR4-mediated
chemotaxis
To dissect the mechanism by which oxyresveratrol
inhibited leukocyte migration, we first examined whether
oxyresveratrol could down-regulate the level of cell sur-
face expression of the chemokine receptor CXCR4.
Jurkat T cells were treated with oxyresveratrol and the
CXCR4 expression level on T cells was measured using
FACS analysis. FACS data showed no difference in the
surface expression of CXCR4 on cells treated with
oxyresveratrol, resveratrol, or DMSO vehicle (Figure 5A),
suggesting that oxyresveratrol does not act at the
chemokine receptor level.Next, we investigated the impact of oxyresveratrol on
the CXCR4 downstream signaling molecules. MAPKs are
known to function downstream of chemokine receptors
[47]; therefore, we examined whether oxyresveratrol
influenced MAPKs in the CXCR4 pathway. Western blot
data showed that oxyresveratrol inhibited SDF-1-mediated
phosphorylation of ERK1/2 kinases (Figure 5B). Con-
versely, it enhanced the SDF-1-mediated phosphorylation
of p38 (Figure 5B). However, oxyresveratrol did not appear
to affect SDF-1-mediated JNK phosphorylation (Figure 5B).
Knowing that oxyresveratrol inhibited the activation of
ERK1/2, we further examined the effect of oxyresveratrol
on the upstream activators of ERK1/2 kinases, MEK1/2
kinases. Accordingly, it suppressed the phosphorylation of
MEK1/2 kinases in the CXCR4 pathway (Figure 5C). These
data demonstrated that oxyresveratrol in M. alba sup-
presses CXCR4-mediated chemotaxis via inactivation of
Figure 4 Effect of crude extract, fractions and compound of M. alba on chemotaxis and cell viability. (A) Jurkat cells were pre-treated
with vehicle (DMSO), the crude extract (CE, 10 μg/ml), butanol fraction (BuOH, 4 μg/ml), ethyl acetate fraction (EA, 4 μg/ml) and water fraction
(H2O, 10 μg/ml) of M. alba for 24 h. The cells were treated with PBS and SDF-1, respectively, for an additional 4 h in transwell microplates. The
number of cells in the bottom well was counted. Cell migration is indicated as migration index (%), as defined in Materials and methods. (B & C)
Jurkat cells were pre-treated with oxyresveratrol at 1, 2.5 and 5 μg/ml. The cells underwent chemotaxis assays (B) or WST-1 test (C) for cell
viability. P (*) < 0.05 is considered statistically significant.
Chen et al. BMC Complementary and Alternative Medicine 2013, 13:45 Page 7 of 10
http://www.biomedcentral.com/1472-6882/13/45
Figure 5 Effect of oxyresveratrol on CXCR4 signaling. (A) Jurkat
cells were pre-treated with oxyresveratrol (2.5 μg/ml), resveratrol
(2.5 μg/ml) or DMSO vehicle for 1 h at 37°C. After extensive washing,
the cells were stained with αCXCR4 (1 μg/ml) and FITC-conjugated
secondary antibody (1 μg/ml) or not. The expression level of CXCR4
on the cell membrane is shown in the histogram. Data are
representative examples of 3 experiments. (B & C) The cells,
pre-treated with oxyresveratrol or DMSO, were stimulated with
SDF-1 (100 ng/ml) for 0 to 15 min. Cell lysates were analyzed by
Western blot with primary antibodies (1 μg/ml) against MAPKs (B),
MEK1/2 (C) or their phosphorylated forms (B & C) plus secondary
antibodies (0.3 μg/ml). The ratio was obtained by normalizing the
signal of the phosphorylated protein to that of the total protein.
(D) A schematic model describing the mechanism by which
oxyresveratrol present in M. alba can inhibit inflammation.
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can be confirmed with normal leukocytes. Moreover, over-
all data suggest that anti-inflammatory herb, M. alba,
and its oxyresveratrol suppress inflammation via inhibi-
tion of leukocyte migration involving the MEK/ERK path-
way (Figure 5D).
Discussion and conclusions
Correct identification and authentication of plants are
absolutely necessary for batch consistency and thera-
peutic efficacy of botanical medicines. M. alba is used in
traditional Chinese medicine for treatment of inflamma-
tory disorders. However, M. alba is sometimes used
interchangeably with, or confused with other Morus
species such as M. atropurpurea and M. bombycis.
A standard method of identification of M. alba versus
M. atropurpurea or M. bombycis has not been es-
tablished, and the similarities/differences between the
chemical and biological properties of these three species
have not been studied. In this work, we first used
chemotaxonomic methods to differentiate M. alba from
the other two species. Spectroscopic methods were used
to analyze the chemical fingerprint of crude extracts,
fractions, and compounds of M. alba. Combined photo-
chemistry and chemotaxis assays were then used for
identification and anti-inflammatory study of M. alba
and oxyresveratrol.
Chemokines and their receptors are involved in nu-
merous diseases and have roles in inflammation and in-
fection. Consequently, the antagonists and inhibitors of
the chemokines and their receptors have become poten-
tial drug targets for inflammatory diseases [41]. M. alba
has been long used as anti-inflammatory remedy in
China. Nevertheless, little is known about its role in
leukocyte migration, a central process linked to inflam-
mation, infection and disease pathogenesis. Here, we
demonstrated that M. alba can suppress leukocyte
migration triggered by CXCR4 (Figure 4). Unexpectedly,
bioassay-guided isolation and identification yielded oxy-
resveratrol as the major active component of the bio-
active ethyl acetate fraction of M. alba (Figure 3).
M. alba possessed a higher abundance of oxyresveratrol
than the other Morus plants (Figure 2). The evidence
presented here that M. alba and its active component,
oxyresveratrol, suppress CXCR4-mediated leukocyte mi-
gration supports the traditional use of M. alba as an
anti-inflammatory medicine.
Oxyresveratrol has been previously reported to exert
anti-inflammatory activity through inhibition of iNOS/NO
production, PGE2 synthesis and NFκB activation [39];
and was reported to reduce carageenan-induced paw
edema in rats likely through inhibition of iNOS expres-
sion [39]. We have also observed oxyresveratrol to
be a more potent inhibitor of leukocyte migration than
Chen et al. BMC Complementary and Alternative Medicine 2013, 13:45 Page 9 of 10
http://www.biomedcentral.com/1472-6882/13/45resveratrol (Figure 4B and data not shown). Our data
on the difference in chemotactic action between
resveratrol and oxyresveratrol are in good agreement
with a previous publication indicating that resveratrol
does not inhibit chemotaxis [47]. Thus, the OH func-
tional group in oxyresveratrol appears to be responsible for
its anti-chemotactic activity. Furthermore, oxyresveratrol
inhibited the activation of the MEK/ERK pathway (Figure 5),
suggesting a possible mechanism by which M. alba and
oxyresveratrol inhibit inflammation.
Following engagement, chemokine receptors induce
an activation of G proteins, tyrosine kinases, serine/
threonine kinases and phospholipases, leading to cell mi-
gration [52,53]. Our results showed that oxyresveratrol,
isolated from M. alba, inhibited the activation of MEK/
ERK kinases, a serine/threonine kinase family, mediated
by CXCR4 in T-cells (Figure 5). However, oxyresveratrol
did not affecte the expression level of CXCR4 receptor
(Figure 4A). These findings suggest that unlike the re-
ceptor antagonists, oxyresveratrol targets the intraceullar
proteins downstream of the chemokine receptors and
may be used as alternative inhibitors of chemokine sig-
naling. Consistently, MAPKs are known to modulate in-
flammatory responses and are thought to be attractive
molecular targets for anti-inflammatory therapy [54].
The manifestation of inactivation of MEK/ERK pathway
by oxyresveratrol makes it extremely interesting poten-
tial natural anti-inflammatory remedy.
In conclusion, we combined phytochemical and chemo-
taxis techniques to study the anti-chemotactic role of the
Morus plants. We demonstrated that M. alba and its
active compound, oxyresveratrol, suppress inflammation
via inhibition of leukocyte chemotaxis. Mechanistic stud-
ies showed that oxyresveratrol inhibits CXCR4-mediated
leukocyte migration via inactivation of the MEK/ERK
pathway downstream of the CXCR4 receptor. These
findings support the claims of the benefits of M. alba
purported in traditional Chinese medicine and suggest the
possible use of the active compound oxyresveratrol as an
anti-inflammation therapy.Additional file
Additional file 1: Table S1. 1H and 13C NMR data on oxyresveratrol
dissolved in CD3COCD3. Figure S1. Ultraviolet (UV) spectra and mass
spectrometry data of oxyresveratrol present in the crude extract and
ethyl acetate fraction of Morus alba and oxyresveratrol. (A) The crude
extract (CE) and ethyl acetate (EA) fraction and resveratrol were subjected
to high performance liquid chromatography (HPLC) and detected with a
diode array detector at 254 nm as described in the Materials and
methods section. The UV spectra of resveratrol (peak 1) are indicated.
Peak 1 corresponds to the same peak as Figure B. (B) Electrospray
ionization mass spectrometry (ESI-MS) spectra of oxyresveratrol present in
the crude extract and ethyl acetate fraction of M. alba and oxyresveratrol.
The crude extract and ethyl acetate fraction of M. alba and oxyresveratrol
were subjected to HPLC-ESI-MS. The MS scans were performed innegative ion mode (m/z 200 to m/z 400). Peaks 1 (31.3 min) of the crude
extract (CE) and ethyl acetate fraction (EA) of M. alba and oxyresveratrol
showed ion signals at m/z 243. Peak 1 corresponds to the same peak as
Figure 3B.
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